Abstract
Background and Aims The 3-question Alcohol Use Disorders Identification Test (AUDIT-C) is frequently used in healthcare for screening and brief advice about levels of alcohol consumption. AUDIT-C scores (0–12) provide feedback as categories of risk rather than estimates of actual alcohol intake, an important metric for behaviour change. The study aimed to (a) develop a continuous metric from the Extended AUDIT-C expressed in United Kingdom (UK) units (8g pure ethanol), offering equivalent accuracy, and providing a direct estimator of weekly alcohol consumption (EWAC) and (b) evaluate the EWAC’s bias and error using the Graduated-Frequency (GF) questionnaire as a reference standard of alcohol consumption.
Design Cross-sectional diagnostic study based on a nationally-representative survey.
Settings Community-dwelling households in England.
Participants 22,404 household residents aged ≥ 16 years reporting drinking alcohol at least occasionally.
Measurements Computer-assisted personal interviews consisting of (a) AUDIT questionnaire with extended response items (the ‘Extended AUDIT’) and (b) GF. Primary outcomes were: mean deviation <1 UK unit (metric of bias); root mean squared deviation <2 UK units (metric of total error) between EWAC and GF. The secondary outcome was the receiver operating characteristic area under the curve for predicting alcohol consumption in excess of 14 and 35 UK units.
Findings EWAC had a positive bias of 0.2 UK units [95% confidence interval: 0.08, 0.4] compared with GF. Deviations were skewed: while the mean error was ±11 UK units/week [9.5, 11.9], in half of participants the deviation between EWAC and GF was between 0 and ±2.1 UK units/week. EWAC predicted consumption in excess of 14 UK units/week with a significantly greater area under the curve (0.918 [0.914, 0.923]) than AUDIT-C (0.870 [0.864, 0.876]) or the full AUDIT (0.854 [0.847, 0.860]).
Conclusions A new estimator of weekly alcohol consumption (EWAC), which uses answers to the Extended Alcohol Use Disorders Identification Test (Extended AUDIT-C), meets the targeted bias tolerance. It is superior in accuracy to AUDIT-C and the full AUDIT when predicting consumption thresholds, making it a reliable complement to the Extended AUDIT-C for health promotion interventions.
Competing Interest Statement
JB has received unrestricted research funding to study smoking cessation from companies who manufacture smoking cessation medications. PD, JH and JMAS declare no competing interests.
Clinical Protocols
Funding Statement
This research was supported by the Medical Research Council [grant reference MR/P016960/1]. The ATS data collection was funded primarily by the National Institute for Health Research (NIHR) School for Public Health Research [grant reference SPHR‐SWP‐ALC‐WP5] and Public Health Research Programme [grant reference 15/63/01]. The EWAC online calculator development was funded by the Wessex Academic Health Science Network. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the University of Southampton's Faculty of Medicine Ethics Committee (ERGO 44682).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Competing interests JB has received unrestricted research funding to study smoking cessation from companies who manufacture smoking cessation medications. PD, JH and JMAS declare no competing interests.
Protocol registration Dutey-Magni, PF, Sinclair, JMA, Brown, J. 2018. ‘Concurrent Validity of an Estimator of Weekly Alcohol Consumption (EWAC) Based on the Extended AUDIT.’ OSF. November 12. doi:10.17605/OSF.IO/7WE4M.
Revisions required by editors with new table 2 and supplementary materials.
Data Availability
ATS data can be requested from the Alcohol Toolkit Study team (jamie.brown{at}ucl.ac.uk).
